FlaggedRx← Medication recall checkHome
Class II · ModerateActive recall

Clonidine Transdermal System

Could cause temporary or reversible harm; serious harm is unlikely.

Does this affect you?
Check your lot numberLot: 100060002, Exp.: 07/2026; 100066802, Exp.: 05/2027
Where it was soldWithin U.S
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

CGMP Deviations: use of an unapproved raw material

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Made byActavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ
Brand nameCLONIDINE TRANSDERMAL SYSTEM
Generic nameCLONIDINE
Active ingredient(s)CLONIDINE
Distributed by / forActavis Pharma, Inc, Parsippany, NJ
NDC0591-3509-04
Show the full FDA record
Full product labelClonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3509-04 carton, NDC 0591-3509-54 pouch
Recalling firmTeva Pharmaceuticals USA, Inc
DistributionWithin U.S
Quantity62,136 Cartons
Recall initiated2026-03-19
Report date2026-04-15
Recall completed—
Recall numberD-0473-2026
ClassificationClass II
FDA statusOngoing
Origin on fileParsippany NJ United States

Related

Recent drug recallsCheck another medication

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.